MY129255A - A new physical form of artemisinin and its use in the production of pharmaceuticals - Google Patents

A new physical form of artemisinin and its use in the production of pharmaceuticals

Info

Publication number
MY129255A
MY129255A MYPI96004715A MYPI9604715A MY129255A MY 129255 A MY129255 A MY 129255A MY PI96004715 A MYPI96004715 A MY PI96004715A MY PI9604715 A MYPI9604715 A MY PI9604715A MY 129255 A MY129255 A MY 129255A
Authority
MY
Malaysia
Prior art keywords
artemisinin
new physical
physical form
pharmaceuticals
production
Prior art date
Application number
MYPI96004715A
Inventor
Chan Kit Dr Lam
Yuen Kah Hay
Mr Sunil U A Jinadasa
Peh Kok Dr Khiang
Original Assignee
Univ Sains Malaysia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Sains Malaysia filed Critical Univ Sains Malaysia
Priority to MYPI96004715A priority Critical patent/MY129255A/en
Priority to ZA9710178A priority patent/ZA9710178B/en
Priority to CN97120284A priority patent/CN1096466C/en
Priority to PE1997001019A priority patent/PE20000016A1/en
Publication of MY129255A publication Critical patent/MY129255A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A NEW PHYSICAL FORM OF ARTEMISININ HAS BEEN IDENTIFIED AS TRICLINIC CRYSTAL. THIS CRYSTAL FORM OF ARTEMISININ HAS GREATER AQUEOUS SOLUBILITY, HIGHER DISSOLUTION RATE AND IMPROVED BIOAVAILABILITY. THE TRICLINIC CRYSTALS CAN BE USED IN THE PREPARATION OF AN ORAL PHARMACEUTICAL SOLID DOSAGE FORM FOR USE AS ANTIMALARIAL DRUG.
MYPI96004715A 1996-11-14 1996-11-14 A new physical form of artemisinin and its use in the production of pharmaceuticals MY129255A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
MYPI96004715A MY129255A (en) 1996-11-14 1996-11-14 A new physical form of artemisinin and its use in the production of pharmaceuticals
ZA9710178A ZA9710178B (en) 1996-11-14 1997-11-12 A new physical form of Artemisinin and its use in the production of pharmaceuticals.
CN97120284A CN1096466C (en) 1996-11-14 1997-11-12 New physical form of artemisinin and its use in production of pharmaceuticals
PE1997001019A PE20000016A1 (en) 1996-11-14 1997-11-13 A NEW PHYSICAL FORM OF ARTEMISININ AND ITS USE IN THE PREPARATION OF PHARMACEUTICAL PRODUCTS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI96004715A MY129255A (en) 1996-11-14 1996-11-14 A new physical form of artemisinin and its use in the production of pharmaceuticals

Publications (1)

Publication Number Publication Date
MY129255A true MY129255A (en) 2007-03-30

Family

ID=19749764

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI96004715A MY129255A (en) 1996-11-14 1996-11-14 A new physical form of artemisinin and its use in the production of pharmaceuticals

Country Status (4)

Country Link
CN (1) CN1096466C (en)
MY (1) MY129255A (en)
PE (1) PE20000016A1 (en)
ZA (1) ZA9710178B (en)

Also Published As

Publication number Publication date
CN1189496A (en) 1998-08-05
ZA9710178B (en) 1998-05-28
PE20000016A1 (en) 2000-02-06
CN1096466C (en) 2002-12-18

Similar Documents

Publication Publication Date Title
ZA200110217B (en) Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application.
DK0991646T3 (en) Itraconazole with improved solubility, method of preparation thereof, and a pharmaceutical composition for oral administration containing
ATE495154T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CCR5 ANTAGONIZING PIPERAZINE DERIVATIVES
MY128809A (en) Pharmaceutical formulation of omeprazole
HUP0201711A3 (en) N-indanyl-benzamide derivatives, method for their production, their use and pharmaceutical preparations containing them
IL191486A0 (en) Piperidine derivatives, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for the treatment of tachykinis mediated conditions
MXPA01011039A (en) 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations.
IL148870A (en) 2'-substituted 1,1'-biphenyl - 2 - carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
HU229443B1 (en) Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use
GR1003658B (en) Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route
FR2778406B1 (en) ALPHA-CETOAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THEM, AND THEIR USE AS ANTI-VIRAL DRUGS
WO2001041742A3 (en) Antiviral medication
ATE287264T1 (en) ORAL MEDICINAL PRODUCTS CONTAINING BUPRENORPHINE
HUP0202934A3 (en) Arylsulfonamido-substituted hydroxamic acid derivatives, process for their preparation, pharmaceutical compositions containing them and use thereof
IL143987A (en) Amidinobenzylamine derivatives, processes for their preparation, pharmaceutical compositions containing them and use of such compositions in the preparation of a medicament for the inhibition of thrombin
WO2000048445A3 (en) Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence
WO2005013935A3 (en) Composition for releasing a weak base for an extended period of time
AU3278800A (en) Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence
EP0271151A3 (en) Azumolene dosage form
EP0649660A3 (en) Pharmaceutical composition for parenteral, enteral and dermal administration of essentially insoluble drugs and process for their preparation.
AU2907800A (en) Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism
DE60032372D1 (en) MEDICINE PREPARATIONS CONTAINING PACLITAXEL INCLUDED IN NANOPARTICLES OF POLYMERIC MICELLES
HUP0203161A3 (en) Benzamidine derivatives, process for their preparation and pharmaceutical compositions containing them and their use
ZA200303276B (en) Stable pharmaceutical form of an anticancer drug and method for production of stable pharmaceutical form of an anticancer drug.
FR2673105B1 (en) NOVEL PHARMACEUTICAL COMPOSITIONS, ESPECIALLY FOR THE TREATMENT OF FUNCTIONAL COLOPATHIES, AND METHODS OF PREPARING COMPOSITIONS AND MEDICAMENTS, ESPECIALLY FOR THE TREATMENT OF THESE CONDITIONS.